Published in N Engl J Med on October 06, 2005
Twenty years of cost-effectiveness analysis in medical imaging: are we improving? Radiology (2008) 1.56
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting. Core Evid (2010) 1.09
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. Radiology (2008) 1.04
MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis. AJR Am J Roentgenol (2014) 0.85
Survival is not the only valuable end point in melanoma screening. J Invest Dermatol (2012) 0.83
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis. Ont Health Technol Assess Ser (2005) 0.82
Medicare and cost-effectiveness analysis. N Engl J Med (2006) 0.75
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
The hospitalist movement 5 years later. JAMA (2002) 8.98
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med (2002) 7.00
Adolescent overweight and future adult coronary heart disease. N Engl J Med (2007) 5.74
Implementation of a voluntary hospitalist service at a community teaching hospital: improved clinical efficiency and patient outcomes. Ann Intern Med (2002) 5.60
Clinical decisions. American Board of Internal Medicine maintenance of certification program. N Engl J Med (2010) 4.85
Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA (2003) 4.45
Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med (2009) 3.83
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med (2002) 3.35
Patient quality of life during the 12 months following joint replacement surgery. Arthritis Rheum (2004) 3.16
beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA (2002) 2.73
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med (2015) 2.72
Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation (2011) 2.64
Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes (2010) 2.63
Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med (2015) 2.47
Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med (2003) 2.13
An exposure indicator for digital radiography: AAPM Task Group 116 (executive summary). Med Phys (2009) 2.00
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST). J Am Coll Cardiol (2004) 1.83
Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. J Pediatr (2010) 1.76
Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation (2006) 1.67
The impact of the aging population on coronary heart disease in the United States. Am J Med (2011) 1.66
Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. Int J Cardiol (2011) 1.61
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes (2014) 1.56
Predictors of stroke in patients paced for sick sinus syndrome. J Am Coll Cardiol (2004) 1.52
Modernizing the paths to certification in internal medicine and its subspecialties. Am J Med (2004) 1.48
Cost effectiveness of aggressive care for patients with nontraumatic coma. Crit Care Med (2002) 1.45
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). Am Heart J (2009) 1.40
Hippocrates affirmed? Limiting residents' work hours does no harm to patients. Ann Intern Med (2007) 1.39
Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health (2009) 1.38
A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. Health Aff (Millwood) (2012) 1.35
Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation (2005) 1.34
Cost-effectiveness of chlorthalidone, amlodipine, and lisinopril as first-step treatment for patients with hypertension: an analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Gen Intern Med (2008) 1.28
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ (2005) 1.18
The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China. BMC Public Health (2008) 1.18
Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med (2009) 1.15
beta-Blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA (2002) 1.15
Critical pathways for patients with acute chest pain at low risk. J Thromb Thrombolysis (2002) 0.97
The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer. Eur J Cardiothorac Surg (2009) 0.97
Assessing and reducing the cardiac risk of noncardiac surgery. Circulation (2006) 0.97
The relation of autopsy rate to physicians' beliefs and recommendations regarding autopsy. Am J Med (2004) 0.97
The decline in coronary heart disease: determining the paternity of success. Am J Med (2004) 0.91
Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law. Tob Control (2012) 0.88
The relationship of insurance status, hospital ownership, and teaching status with interhospital transfers in California in 2000. Acad Med (2005) 0.85
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm (2006) 0.84
[The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Rev Panam Salud Publica (2012) 0.82
Value of immediate postoperative electrocardiogram to update risk stratification after major noncardiac surgery. Am J Cardiol (2004) 0.82
A case for the 80 duty-hour week. Am J Med (2004) 0.80
Preoperative risk evaluation and perioperative management of patients with coronary artery disease. Med Clin North Am (2003) 0.79
Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing. Pacing Clin Electrophysiol (2003) 0.79
The revised cardiac risk index delivers what it promised. Ann Intern Med (2010) 0.79
Aortic stenosis in noncardiac surgery: underappreciated in more ways than one? Am J Med (2004) 0.78
Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction. Circulation (2005) 0.78
Passing the clinical baton: 6 principles to guide the hospitalist. Dis Mon (2002) 0.78
Projected impact of urbanization on cardiovascular disease in China. Int J Public Health (2012) 0.78
Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients: a cost-effectiveness analysis. Circulation (2011) 0.77
Death in patients with permanent pacemakers for sick sinus syndrome. Am Heart J (2003) 0.77
Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory Society (ERS). Interact Cardiovasc Thorac Surg (2009) 0.77
Clinical and quality of life comparison of accelerometer, piezoelectric crystal, and blended sensors in DDDR-paced patients with sinus node dysfunction in the mode selection trial (MOST). Pacing Clin Electrophysiol (2005) 0.77
Bleeding is rarely good for you. Circulation (2012) 0.75
Evidence-based perioperative risk reduction. Am J Med (2003) 0.75
Superficial phlebitis and phase 3.5 trials. N Engl J Med (2010) 0.75
Letter by Lee and Goldman regarding article, "Development and validation of a risk calculator for prediction of cardiac risk after surgery". Circulation (2012) 0.75
40 years of training physician-scientists: a journey from clinical pearls to evidence-based practice and policies. Ann Intern Med (2014) 0.75
Statins for Primary Prevention in Adults Aged 75 Years or Older. Ann Intern Med (2015) 0.75
Inhalation anthrax revisited. Am J Med (2002) 0.75
Overlapping publications. Am J Med (2003) 0.75
Alvan Feinstein: A tribute to quality and caring. Am J Med (2002) 0.75
Triplicate publication, not an epidemic. Am J Med (2002) 0.75
Improving adherence--money isn't the only thing. N Engl J Med (2011) 0.75
Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare? Nat Clin Pract Cardiovasc Med (2008) 0.75
Health values before and after pacemaker implantation. Am Heart J (2002) 0.75